CBD

Japanese Cannabis Reform Is Almost Here
This CBD And Hemp Co. Reports 82% YoY Increase In 2023 Revenue, Thanks To Its 'International Appeal'
Pakistan Launches Regulatory Body For Cannabis Trade To Fuel Economic Growth
This CBD And Hemp Co. Reports 82% YoY Increase In 2023 Revenue, Thanks To Its 'International Appeal'
Pakistan Launches Regulatory Body For Cannabis Trade To Fuel Economic Growth
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
Functional Cannabis With Pharma Nanotech? How KanhaFX Boosts Cannabinoid Delivery And Market Share

CBD Recent News

NFL Legends Calvin Johnson & Rob Sims Launch First-Ever CBD Brand At Ford Field In Milestone Partnership
In an unprecedented move, Ford Field welcomed cannabis brand Primitiv as its official performance partner in launching Primitiv Performance a potent drink mix featuring CBD, electrolytes and vitamins as well as broad spectrum (
CBD A Potent Alternative For Dental Pain Management, Says Study
Research shows CBD as effective alternative to opioids for dental pain. CBD's advantages over traditional analgesics offer a safer option for pain management and a catalyst for change in the medical community.
CBD-Focused Charlotte's Web Narrows Net Loss 75% YoY In Q4, Reports Drop In Revenue
Charlotte's Web Holdings, Inc. reported on Thursday financial results for the fourth quarter and year ended Dec. 31, 2023. The Louisville, Colorado-based hemp extract wellness producer reported a 16% year-over-year decrease in fourth-quarter consolidated net revenue to $15.9 million. The company said both retail and e-commerce revenues lower year-over-year. Charlotte's Web said CBD product sales remain below expectations, attributing it to "ongoing headwinds in the overall CBD category, including regulatory ambiguities at the federal and state levels, associated consumer confusion, and competitive crowding and pricing pressures."
E-Commerce Giants Exposed: 'Hemp Gummies' On Amazon Mask Unsafe Delta-8 THC Levels, New Report Reveals
Report unveils risky delta-8 THC in "hemp gummies" on Amazon, Walmart, eBay. Study exposes mislabeling, calls for strict enforcement.
Arizona AG Restricts Hemp Sales, Maine Will Expunge Pre-Legalization Convictions, Ohio Cannabis School First To Earn Official Accreditation And More
Explore the latest cannabis regulatory updates across the US, including key changes in Arizona, Maine, Ohio, and Alabama. Read now!
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your parent's love, you must raise children yourself.' Today's story is about a mother who once moved mountains for her daughter and continues to do the same for other struggling parents with children who are ill.
Sweet Success: The Bettering Company Crafts The Future Of Cannabis Creativity, One Bite At A Time
The Bettering Company creates superior cannabis edibles with a focus on health, creativity, and social responsibility. Founder Mark Cozzi aims to offer healthier alternatives and expand their reach.
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a significant advancement in ASD treatment. CEO Oz Adler expressed excitement about this milestone, highlighting the potential impact of the SCI-210 therapy in managing ASD symptoms. The company plans to enroll 60 participants aged 5 to 18 for a 20-week trial, comparing SCI-210 therapy with standard CBD treatment, in collaboration with the National Autism Research Center. Partnering with Tikun Olam Cannbit Pharmaceuticals Ltd., SciSparc aims to bring SCI-210 to market in Israel initially, with global distribution pending regulatory approvals. Additionally, the company achieved patent approvals in Canada for their opioid and n-acylethanolamine combination for pain management, as well as validation for their core technology patent in 15 European countries, demonstrating their commitment to advancing cannabinoid-based therapeutics.
Science Confirms Safe, Effective Daily Dose Of CBD For Dogs - Long-Term And No Risks
A recent study published in Frontiers in Veterinary Science reveals that healthy dogs can safely consume cannabinoids like CBD, CBDA, and CBG daily with minimal risk over the long term. The study, which involved 32 healthy beagle dogs, showed that these cannabinoids were well-tolerated when given at a dose of 5 mg/kg body weight/day for 90 consecutive days. The National Animal Supplement Council (NASC) highlighted these findings, stating that different cannabidiols are safe for long-term use in healthy dogs. This research contributes to a growing body of evidence on the positive effects of cannabis on animals. Previous studies have shown that CBD can reduce pain and improve mobility in arthritic dogs, as well as relieve stress in dogs during car travel or when left alone.
Isiah Thomas, Stephen Marley Collaboration Launches CBD-Enriched Muscle Rub
Discover Pro-11, a CBD muscle rub by Isiah Thomas' One World Products & Stephen Marley, designed for athletes' peak performance and recovery.
Rare Weed Compound Helps Suppress Appetite, Increases Energy & Motivation Without The Munchies, New Study Finds
Phylos, a cannabis genetics company and People Science, conducted a groundbreaking research study on the rare cannabinoid tetrahydrocannabivarin (THCV). The study, which showed promising results, revealed that Natural THCV developed by Phylos led to improved energy levels, productivity, motivation, and overall happiness without common side effects like fatigue and increased appetite associated with consuming THC. Alisha Holloway, PhD, the chief scientific officer at Phylos, highlighted the importance of this study for the cannabis industry. The study involved subjects consuming placebo gummies, THC-only gummies, and gummies containing the Get Sh!t Done (GSD) extract, high in THCV. Research findings indicated that THCV-enriched gummies were more effective in enhancing activity levels, exercise performance, motivation, and overall well-being compared to THC-only gummies. The discovery of THCV, a unique cannabis compound, has opened up new possibilities for targeted cannabis products with potential benefits such as appetite suppression and blood sugar regulation.
Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
The Food and Drug Administration (FDA) has indicated a proactive stance toward establishing a regulatory framework for Cannabidiol (CBD) while continuing to monitor kratom closely.
Mexico Welcomes Legal CBD: Xebra Brands & ICAN Pave The Way With CBD Supply Deal
Xebra Brands partners with ICAN to supply legal CBD in Mexico, marking a milestone for the industry with the first Mexican-made CBD products.
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
Cannabinoid-focused pharmaceutical company Innocan Pharma Corp expects preliminary revenues of $4.89m in Q4 of fiscal 2023, representing a YoY increase of 331%. It said preliminary revenues are expected to be at least $13.6m for the whole of the fiscal year, a 433% YoY increase. Its subsidiary B.I. Sky Global drove the increase in sales. Innocan is currently pursuing FDA approval for its human pharmaceutical applications following successful pre-clinical trials, and the company expects pre-investigational new drug applications to be submitted to the FDA before the end of the month. Innocan has developed a long-lasting and therapeutic liposomal formulation for CBD called LPT Solution, which administers injectable CBD encapsulated in liposomes to achieve long-lasting therapeutic levels of CBD in the body. The company said the technology creates a more effective and prolonged therapeutic effect. Innocan plans to test the LPT platform on a new animal species in the near future.
Ailing Elephant Improves With Cannabis-Based Treatment, How Vets Are Turning To Alternatives For Animal Care
Explore the use of cannabis in veterinary medicine, from treating elephants to pets. Discover the latest research and global perspectives.
Brooklyn Nets And WNBA NY Liberty Enter Landmark CBD Sponsorship With Mynd Drinks
Discover how the Brooklyn Nets & NY Liberty lead the NBA with a historic CBD sponsorship, marking a pivotal shift in sports wellness.
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will commercialise Avicanna's RHO Phyto brand in Europe for the first time. The company praised its own proprietary patent-protected technologies being entered into "the European market without competition" as testament to its "scientific and technical leadership in the cannabinoid clinical and commercialisation field", highlighting the deal's strategic nature and geographic position, as well as the expected rapid expansion into other European countries. The unnamed pharmaceutical company manufactures and markets a wide range of pharmaceuticals across four continents and has established a commercial infrastructure in Europe. These manufacturing plants will produce Avicanna's Ultra-CBD cream and CBG Transdermal Gel in 2024.
Game Changing Move? NFL Tackles Pain And Concussions In CBD Clinical Trial Partnership With Canadian University
The NFL is teaming up with Canadian researchers to delve into the potential of cannabidiol (CBD) for pain management and neuroprotection from concussions, both significant concerns for its players. This Phase 1 trial marks a first step in exploring the non-intoxicating cannabinoid's therapeutic potential.
High-Performance Fitness: New Study Reveals Interplay Between Cannabis Use And Exercise Experience
In a recent study published in Sports Medicine, researchers from the University of Colorado delved into the intricate relationship between cannabis consumption and exercise, aiming to uncover how legal-market cannabis affects regular marijuana users during immediate responses to exercise in a controlled laboratory
CBD-Infused Tampons Offer Safe And Effective Alternative For Menstrual Pain Treatment, Study Says
By Lucía Tedesco via El Planteo The use of CBD-infused tampons as a treatment for menstrual pain has been the focus of recent study.
New Study Finds Diverse Views Among Sports Medicine Doctors On Marijuana Use, Highlights CBD
Conducted by members of the American Medical Society for Sports Medicine (AMSSM), the study shed light on the perspectives of sports medicine doctors regarding cannabinoid use with a primary focus on cannabidiol (CBD).
Turning Sugars Into Pure, Rare Cannabinoids:This Company's Breakthrough
In an exclusive interview with Benzinga, Dr. Shane Johnson, MD, senior vice president and general manager of BayMedica, sheds light on the company's innovative approach to cannabinoid production.
Federally Funded Study Shows Delta-8 THC Use Rises In States Where Marijuana Remains Illegal
A new federally funded study delves into cannabinoid use trends in the United States.